Real-time enrollment status for this generalized anxiety disorder clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 3:23 PM UTC
| NCT Number | NCT06846320 |
| Recruiting Status | Recruiting |
| Condition | Generalized Anxiety Disorder |
| Phase | Clinical Trial |
| Target Enrollment | 315 participants |
| Active Locations | 43 sites in the US |
| Sponsor | AbbVie |
| Last Updated on CT.gov | January 23, 2026 (Jan 23, 2026) |
As of March 2, 2026: Clinical trial NCT06846320 is currently recruiting participants. This clinical trial study for generalized anxiety disorder is actively seeking new participants at 43 locations across the United States. The study is sponsored by AbbVie. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06846320 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 43 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06846320 was last updated Jan 23, 2026 (January 23, 2026). HelloStudys verifies this status automatically.